Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
This is the complete answer, not a partial one — the list is never padded.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Evert Schimmelpennink | $690,000 | $0 | $0 | $5,793,809 | $538,200 | $0 | $14,000 | $7,036,009 |
| President and Chief Executive Officer | ||||||||
| Marc Odrich | 500,000 | 0 | 0 | 1,662,788 | 260,000 | 0 | 14,000 | 2,436,788 |
| Chief Medical Officer | ||||||||
| Shawn Olsson | 467,500 | 0 | 0 | 1,662,788 | 243,100 | 0 | 14,000 | 2,387,388 |
| Chief Commercial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Evert Schimmelpennink | $7,036,009 | — | — | — |
| Marc Odrich | 2,436,788 | — | — | — |
| Shawn Olsson | 2,387,388 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Evert Schimmelpennink | Option | 98,708 | 6.04 | — |
| Evert Schimmelpennink | Option | 267,188 | 15.05 | — |
| Evert Schimmelpennink | Option | 279,100 | 26.34 | — |
| Marc Odrich | Option | 20,773 | 6.04 | — |
| Marc Odrich | Option | 59,063 | 15.05 | — |
| Marc Odrich | Option | 80,100 | 26.34 | — |
| Shawn Olsson | Option | 15,911 | 6.04 | — |
| Shawn Olsson | Option | 59,063 | 15.05 | — |
| Shawn Olsson | Option | 80,100 | 26.34 | — |
We believe our compensation program should promote the success of the company and align executive incentives with the long-term interests of our stockholders.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | — |
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jeff GeorgeIndependent · Nominating and Corporate Governance (Chair) | $80,000 | $0 | $304,081 | — | $0 | $384,081 |
| Shelley ThunenIndependent · Audit (Chair) · Compensation · Nominating and Corporate Governance | 61,000 | 0 | 304,081 | — | 0 | 365,081 |
| Frederic GuerardIndependent · Audit · Compensation (Chair) | 59,500 | 0 | 304,081 | — | 0 | 363,581 |
| Zach ScheinerIndependent · Audit · Nominating and Corporate Governance | 52,500 | 0 | 304,081 | — | 0 | 356,581 |
| Kimberlee C. DrapkinIndependent · Nominating and Corporate Governance · Compensation | 51,000 | 0 | 304,081 | — | 0 | 355,081 |
| James McCollumIndependent | 40,000 | 0 | 304,081 | — | 0 | 344,081 |
| Evert SchimmelpenninkEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $344,000 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $344,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | LENZ Therapeutics | 2025 | Evert Schimmelpennink | $690,000 | $0 | $5,793,809 | $538,200 | $7,036,009 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Evert Schimmelpennink | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Executive Compensation”. As printed: 7,036,009. Filing ↗machine: r3 · c36 · span 295403–295412 |
| 2 | Section 01, Marc Odrich | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Executive Compensation”. As printed: 2,436,788. Filing ↗machine: r6 · c36 · span 301154–301163 |
| 3 | Section 01, Shawn Olsson | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Executive Compensation”. As printed: 2,387,388. Filing ↗machine: r9 · c36 · span 307192–307201 |
| 4 | Section 07, pay ratio | 10-K | 2026-03-24 | 0001815776-26-000011 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 5 | Section 08, Jeff George | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 384,081. Filing ↗machine: span 220134–220141 |
| 6 | Section 08, Shelley Thunen | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 365,081. Filing ↗machine: span 226390–226397 |
| 7 | Section 08, Frederic Guerard | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 363,581. Filing ↗machine: span 222238–222245 |
| 8 | Section 08, Zach Scheiner | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 356,581. Filing ↗machine: span 228465–228472 |
| 9 | Section 08, Kimberlee C. Drapkin | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 355,081. Filing ↗machine: span 230547–230554 |
| 10 | Section 08, James McCollum | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 344,081. Filing ↗machine: span 224314–224321 |
| 11 | Section 08, Evert Schimmelpennink | DEF 14A | 2026-04-28 | 0001815776-26-000026 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 12 | Section 09b board cost (computed) | Computed | — | computed | Cash 344,000 + equity 0 + all other 0 = 344,000, summed across the director compensation table rows.machine: formula: Σ = 344,000 |
| 13 | LENZ Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001815776-26-000026 | CEO total compensation as printed in LENZ Therapeutics's own proxy. As printed: 7,036,009. Filing ↗machine: r3 · c36 · span 295403–295412 |